Clinical Trial Update: Study of an Anti-TLR4 mAb in Rheumatoid Arthritis [Phase 2]

View source ↗

Summary

Phase 2 study of an anti-TLR4 monoclonal antibody in rheumatoid arthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• anti-TLR4 monoclonal antibody

Snippet

Sponsor: Light Chain Bioscience - Novimmune SA | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED